person · Reporting owner
Weber Kathleen Gallagher
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ORASURE TECHNOLOGIES INCOSUR · Entity 6152 | Chief Product Officer | March 01, 2025 | March 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ORASURE TECHNOLOGIES INC
Report date March 01, 2025 · Filed March 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 391,206 |
Ending reported balance
After 2025-03-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-03-01 · Grant · Acquired 88,148 · Balance 399,518 F1: Grant of restricted stock award vesting in three equal annual installments beginning on March 1, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates. Row 2 · 2025-03-01 · Tax withholding · Disposed 8,312 · Balance 391,206 F2: Withholding of shares to pay the tax liability associated with vesting of restricted shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock award vesting in three equal annual installments beginning on March 1, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2: Withholding of shares to pay the tax liability associated with vesting of restricted shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2019 Filed Feb 5, 2019 21:54 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Tax withholdingCommon Stock | 760 | $12.98 | $9,866.70 |
DisclosureSEC source: 0001593968-19-000351 · primary_01.xml · nonDerivative · entry 3 Weber Kathleen Gallagher · CIK 0001756089 · EVP & BU Lead - Molecular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,169 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:54 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Tax withholdingCommon Stock | 1,260 | $12.98 | $16,357.95 |
DisclosureSEC source: 0001593968-19-000351 · primary_01.xml · nonDerivative · entry 2 Weber Kathleen Gallagher · CIK 0001756089 · EVP & BU Lead - Molecular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,929 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:54 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Tax withholdingCommon Stock | 2,985 | $12.98 | $38,752.76 |
DisclosureSEC source: 0001593968-19-000351 · primary_01.xml · nonDerivative · entry 1 Weber Kathleen Gallagher · CIK 0001756089 · EVP & BU Lead - Molecular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,189 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.